Cox-2 Inhibitors Market - Global Outlook and Forecast 2023-2028

Report ID: 1370443 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Cox-2 Inhibitors Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Cox-2 Inhibitors Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Cox-2 Inhibitors Overall Market Size
    2.1 Global Cox-2 Inhibitors Market Size: 2021 VS 2028
    2.2 Global Cox-2 Inhibitors Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Cox-2 Inhibitors Players in Global Market
    3.2 Top Global Cox-2 Inhibitors Companies Ranked by Revenue
    3.3 Global Cox-2 Inhibitors Revenue by Companies
    3.4 Top 3 and Top 5 Cox-2 Inhibitors Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Cox-2 Inhibitors Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Cox-2 Inhibitors Players in Global Market
        3.6.1 List of Global Tier 1 Cox-2 Inhibitors Companies
        3.6.2 List of Global Tier 2 and Tier 3 Cox-2 Inhibitors Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Cox-2 Inhibitors Market Size Markets, 2021 & 2028
        4.1.2 Selective Cox-2 Inhibitors
        4.1.3 Non Selective Cox-2 Inhibitors
    4.2 By Type - Global Cox-2 Inhibitors Revenue & Forecasts
        4.2.1 By Type - Global Cox-2 Inhibitors Revenue, 2017-2022
        4.2.2 By Type - Global Cox-2 Inhibitors Revenue, 2023-2028
        4.2.3 By Type - Global Cox-2 Inhibitors Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Cox-2 Inhibitors Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global Cox-2 Inhibitors Revenue & Forecasts
        5.2.1 By Application - Global Cox-2 Inhibitors Revenue, 2017-2022
        5.2.2 By Application - Global Cox-2 Inhibitors Revenue, 2023-2028
        5.2.3 By Application - Global Cox-2 Inhibitors Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Cox-2 Inhibitors Market Size, 2021 & 2028
    6.2 By Region - Global Cox-2 Inhibitors Revenue & Forecasts
        6.2.1 By Region - Global Cox-2 Inhibitors Revenue, 2017-2022
        6.2.2 By Region - Global Cox-2 Inhibitors Revenue, 2023-2028
        6.2.3 By Region - Global Cox-2 Inhibitors Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Cox-2 Inhibitors Revenue, 2017-2028
        6.3.2 US Cox-2 Inhibitors Market Size, 2017-2028
        6.3.3 Canada Cox-2 Inhibitors Market Size, 2017-2028
        6.3.4 Mexico Cox-2 Inhibitors Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Cox-2 Inhibitors Revenue, 2017-2028
        6.4.2 Germany Cox-2 Inhibitors Market Size, 2017-2028
        6.4.3 France Cox-2 Inhibitors Market Size, 2017-2028
        6.4.4 U.K. Cox-2 Inhibitors Market Size, 2017-2028
        6.4.5 Italy Cox-2 Inhibitors Market Size, 2017-2028
        6.4.6 Russia Cox-2 Inhibitors Market Size, 2017-2028
        6.4.7 Nordic Countries Cox-2 Inhibitors Market Size, 2017-2028
        6.4.8 Benelux Cox-2 Inhibitors Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Cox-2 Inhibitors Revenue, 2017-2028
        6.5.2 China Cox-2 Inhibitors Market Size, 2017-2028
        6.5.3 Japan Cox-2 Inhibitors Market Size, 2017-2028
        6.5.4 South Korea Cox-2 Inhibitors Market Size, 2017-2028
        6.5.5 Southeast Asia Cox-2 Inhibitors Market Size, 2017-2028
        6.5.6 India Cox-2 Inhibitors Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Cox-2 Inhibitors Revenue, 2017-2028
        6.6.2 Brazil Cox-2 Inhibitors Market Size, 2017-2028
        6.6.3 Argentina Cox-2 Inhibitors Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Cox-2 Inhibitors Revenue, 2017-2028
        6.7.2 Turkey Cox-2 Inhibitors Market Size, 2017-2028
        6.7.3 Israel Cox-2 Inhibitors Market Size, 2017-2028
        6.7.4 Saudi Arabia Cox-2 Inhibitors Market Size, 2017-2028
        6.7.5 UAE Cox-2 Inhibitors Market Size, 2017-2028
7 Players Profiles
    7.1 Bayer
        7.1.1 Bayer Corporate Summary
        7.1.2 Bayer Business Overview
        7.1.3 Bayer Cox-2 Inhibitors Major Product Offerings
        7.1.4 Bayer Cox-2 Inhibitors Revenue in Global Market (2017-2022)
        7.1.5 Bayer Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Cox-2 Inhibitors Major Product Offerings
        7.2.4 Novartis Cox-2 Inhibitors Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Pfizer
        7.3.1 Pfizer Corporate Summary
        7.3.2 Pfizer Business Overview
        7.3.3 Pfizer Cox-2 Inhibitors Major Product Offerings
        7.3.4 Pfizer Cox-2 Inhibitors Revenue in Global Market (2017-2022)
        7.3.5 Pfizer Key News
    7.4 Merck
        7.4.1 Merck Corporate Summary
        7.4.2 Merck Business Overview
        7.4.3 Merck Cox-2 Inhibitors Major Product Offerings
        7.4.4 Merck Cox-2 Inhibitors Revenue in Global Market (2017-2022)
        7.4.5 Merck Key News
    7.5 Cadila Pharmaceuticals
        7.5.1 Cadila Pharmaceuticals Corporate Summary
        7.5.2 Cadila Pharmaceuticals Business Overview
        7.5.3 Cadila Pharmaceuticals Cox-2 Inhibitors Major Product Offerings
        7.5.4 Cadila Pharmaceuticals Cox-2 Inhibitors Revenue in Global Market (2017-2022)
        7.5.5 Cadila Pharmaceuticals Key News
    7.6 Sabinsa Corporation
        7.6.1 Sabinsa Corporation Corporate Summary
        7.6.2 Sabinsa Corporation Business Overview
        7.6.3 Sabinsa Corporation Cox-2 Inhibitors Major Product Offerings
        7.6.4 Sabinsa Corporation Cox-2 Inhibitors Revenue in Global Market (2017-2022)
        7.6.5 Sabinsa Corporation Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Cox-2 Inhibitors Market Opportunities & Trends in Global Market
    Table 2. Cox-2 Inhibitors Market Drivers in Global Market
    Table 3. Cox-2 Inhibitors Market Restraints in Global Market
    Table 4. Key Players of Cox-2 Inhibitors in Global Market
    Table 5. Top Cox-2 Inhibitors Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Cox-2 Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Cox-2 Inhibitors Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Cox-2 Inhibitors Product Type
    Table 9. List of Global Tier 1 Cox-2 Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Cox-2 Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Cox-2 Inhibitors Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Cox-2 Inhibitors Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Cox-2 Inhibitors Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Cox-2 Inhibitors Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Cox-2 Inhibitors Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Cox-2 Inhibitors Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Cox-2 Inhibitors Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Cox-2 Inhibitors Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Cox-2 Inhibitors Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Cox-2 Inhibitors Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Cox-2 Inhibitors Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Cox-2 Inhibitors Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Cox-2 Inhibitors Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Cox-2 Inhibitors Revenue, (US$, Mn), 2023-2028
    Table 30. Bayer Corporate Summary
    Table 31. Bayer Cox-2 Inhibitors Product Offerings
    Table 32. Bayer Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis Cox-2 Inhibitors Product Offerings
    Table 35. Novartis Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 36. Pfizer Corporate Summary
    Table 37. Pfizer Cox-2 Inhibitors Product Offerings
    Table 38. Pfizer Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 39. Merck Corporate Summary
    Table 40. Merck Cox-2 Inhibitors Product Offerings
    Table 41. Merck Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 42. Cadila Pharmaceuticals Corporate Summary
    Table 43. Cadila Pharmaceuticals Cox-2 Inhibitors Product Offerings
    Table 44. Cadila Pharmaceuticals Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
    Table 45. Sabinsa Corporation Corporate Summary
    Table 46. Sabinsa Corporation Cox-2 Inhibitors Product Offerings
    Table 47. Sabinsa Corporation Cox-2 Inhibitors Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Cox-2 Inhibitors Segment by Type in 2021
    Figure 2. Cox-2 Inhibitors Segment by Application in 2021
    Figure 3. Global Cox-2 Inhibitors Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Cox-2 Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Cox-2 Inhibitors Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Cox-2 Inhibitors Revenue in 2021
    Figure 8. By Type - Global Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 12. US Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 16. Germany Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 17. France Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 24. China Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 28. India Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 30. Brazil Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Cox-2 Inhibitors Revenue Market Share, 2017-2028
    Figure 33. Turkey Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Cox-2 Inhibitors Revenue, (US$, Mn), 2017-2028
    Figure 37. Bayer Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Pfizer Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Merck Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Cadila Pharmaceuticals Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Sabinsa Corporation Cox-2 Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
Cox-2 Inhibitors Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cox-2 Inhibitors Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cox-2 Inhibitors Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports